ArticleScientific reports2025
Machine learning models for predicting multimorbidity trajectories in middle-aged and elderly adults.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Article
- Analysis of depressive symptom trajectory patterns with zuranolone: Time-series clustering of Japanese Phase 2 and Phase 3 trial data.PCN reports : psychiatry and clinical neurosciences · 2026Article
- Nurses as guardians of time: the hidden clinical value of continuous care in geriatrics.Frontiers in public health · 2026Review
- Artificial Intelligence for Multimorbidity: Managing Complexity at Scale.International journal of public health · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Multimorbidity has emerged as a significant public health issue in the context of global population aging. Predicting and managing the progression of multimorbidity in the elderly population is crucial. This study aims to develop predictive models for multimorbidity trajectories in middle-aged and elderly populations and to identify the key factors influencing the progression of multimorbidity. First, a time-series clustering method was used to construct the multimorbidity trajectories. Then, predictive models based on machine learning techniques were developed to forecast the progression of different trajectories and identify key risk factors. This study utilized data from the China Health and Retirement Longitudinal Study (CHARLS) database, including 12,198 middle-aged and elderly individuals (aged 45 and above). Four distinct multimorbidity progression patterns were identified: Stable Low-Risk Group (45.26%), Progressively Worsening Group (14.35%), Moderate Stability Group (31.90%) and Consistently Deteriorating Group (8.49%). Among the predictive models, the XGBoost model achieved the best performance, with an accuracy of 0.664 (95%CI: 0.648-0.681), a macro ROC-AUC of 0.825 (95%CI: 0.816-0.834), a micro ROC-AUC of 0.884 (95%CI: 0.876-0.892), and a log loss of 0.806 (95%CI: 0.781-0.831). Other models, including Random Forest, Support Vector Machine, Logistic Regression, and Artificial Neural Networks, showed similar accuracy and ROC-AUC values. The study identified three key factors-baseline disease counts, self-rated Activities of Daily Living (ADL), and self-rated health status-as critical predictors of multimorbidity trajectories.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.